Your browser doesn't support javascript.
loading
Sotatercept with long-term extension for the treatment of anaemia in patients with lower-risk myelodysplastic syndromes: a phase 2, dose-ranging trial.
Komrokji, Rami; Garcia-Manero, Guillermo; Ades, Lionel; Prebet, Thomas; Steensma, David P; Jurcic, Joseph G; Sekeres, Mikkael A; Berdeja, Jesus; Savona, Michael R; Beyne-Rauzy, Odile; Stamatoullas, Aspasia; DeZern, Amy E; Delaunay, Jacques; Borthakur, Gautam; Rifkin, Robert; Boyd, Thomas E; Laadem, Abderrhamane; Vo, Bond; Zhang, Jennie; Puccio-Pick, Marie; Attie, Kenneth M; Fenaux, Pierre; List, Alan F.
Afiliación
  • Komrokji R; Department of Malignant Hematology, Moffitt Cancer Center and Research Institute, Tampa, FL, USA. Electronic address: rami.komrokji@moffitt.org.
  • Garcia-Manero G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Ades L; Hospital St Louis, Paris 7 University, Paris, France.
  • Prebet T; Department of Internal Medicine, Section of Hematology, Yale University School of Medicine, New Haven, CT, USA.
  • Steensma DP; Division of Hematological Malignancies, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Jurcic JG; Division of Hematology/Oncology, Department of Medicine, Columbia University Medical Center, New York, NY, USA.
  • Sekeres MA; Leukemia Program, Cleveland Clinic, Cleveland, OH, USA.
  • Berdeja J; Sarah Cannon Research Institute, Nashville, TN, USA.
  • Savona MR; Vanderbilt University Medical Center, Nashville, TN, USA.
  • Beyne-Rauzy O; Department of Internal Medicine, CHU Toulouse, Paul Sabatier University, Toulouse, France.
  • Stamatoullas A; Clinical Hematology, Centre Henri Becquerel, Rouen, France.
  • DeZern AE; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, USA.
  • Delaunay J; Department of Hematology, Nantes University Hospital, Nantes, France.
  • Borthakur G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Rifkin R; US Oncology Research and Rocky Mountain Cancer Centers, Denver, CO, USA.
  • Boyd TE; Willamette Valley Cancer Institute, Eugene, OR, USA.
  • Laadem A; Celgene Corporation, Summit, NJ, USA.
  • Vo B; Celgene Corporation, Summit, NJ, USA.
  • Zhang J; Celgene Corporation, Summit, NJ, USA.
  • Puccio-Pick M; Celgene Corporation, Summit, NJ, USA.
  • Attie KM; Acceleron Pharma, Cambridge, MA, USA.
  • Fenaux P; Hospital St Louis, Paris 7 University, Paris, France.
  • List AF; Department of Malignant Hematology, Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
Lancet Haematol ; 5(2): e63-e72, 2018 Feb.
Article en En | MEDLINE | ID: mdl-29331635
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Síndromes Mielodisplásicos / Proteínas Recombinantes de Fusión / Inmunoglobulina G / Anemia Tipo de estudio: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male Idioma: En Revista: Lancet Haematol Año: 2018 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Síndromes Mielodisplásicos / Proteínas Recombinantes de Fusión / Inmunoglobulina G / Anemia Tipo de estudio: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male Idioma: En Revista: Lancet Haematol Año: 2018 Tipo del documento: Article